Cargando…

Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort

AIM: Although clinicians primarily diagnose dementia based on a combination of metrics such as medical history and formal neuropsychological tests, recent work using linguistic analysis of narrative speech to identify dementia has shown promising results. We aim to build upon research by Thomas JA &...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Larry, Ngo, Anthony, Thomas, Jason A., Burkhardt, Hannah A., Parsey, Carolyn M., Au, Rhoda, Ghomi, Reza Hosseini
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570561/
https://www.ncbi.nlm.nih.gov/pubmed/34746927
http://dx.doi.org/10.37349/emed.2021.00044
_version_ 1784594863279308800
author Zhang, Larry
Ngo, Anthony
Thomas, Jason A.
Burkhardt, Hannah A.
Parsey, Carolyn M.
Au, Rhoda
Ghomi, Reza Hosseini
author_facet Zhang, Larry
Ngo, Anthony
Thomas, Jason A.
Burkhardt, Hannah A.
Parsey, Carolyn M.
Au, Rhoda
Ghomi, Reza Hosseini
author_sort Zhang, Larry
collection PubMed
description AIM: Although clinicians primarily diagnose dementia based on a combination of metrics such as medical history and formal neuropsychological tests, recent work using linguistic analysis of narrative speech to identify dementia has shown promising results. We aim to build upon research by Thomas JA & Burkardt HA et al. (J Alzheimers Dis. 2020;76:905-22) and Alhanai et al. (arXiv:1710.07551v1. 2020) on the Framingham Heart Study (FHS) Cognitive Aging Cohort by 1) demonstrating the predictive capability of linguistic analysis in differentiating cognitively normal from cognitively impaired participants and 2) comparing the performance of the original linguistic features with the performance of expanded features. METHODS: Data were derived from a subset of the FHS Cognitive Aging Cohort. We analyzed a sub-selection of 98 participants, which provided 127 unique audio files and clinical observations (n = 127, female = 47%, cognitively impaired = 43%). We built on previous work which extracted original linguistic features from transcribed audio files by extracting expanded features. We used both feature sets to train logistic regression classifiers to distinguish cognitively normal from cognitively impaired participants and compared the predictive power of the original and expanded linguistic feature sets, and participants’ Mini-Mental State Examination (MMSE) scores. RESULTS: Based on the area under the receiver-operator characteristic curve (AUC) of the models, both the original (AUC = 0.882) and expanded (AUC = 0.883) feature sets outperformed MMSE (AUC = 0.870) in classifying cognitively impaired and cognitively normal participants. Although the original and expanded feature sets had similar AUC, the expanded feature set showed better positive and negative predictive value [expanded: positive predictive value (PPV) = 0.738, negative predictive value (NPV) = 0.889; original: PPV = 0.701, NPV = 0.869]. CONCLUSIONS: Linguistic analysis has been shown to be a potentially powerful tool for clinical use in classifying cognitive impairment. This study expands the work of several others, but further studies into the plausibility of speech analysis in clinical use are vital to ensure the validity of speech analysis for clinical classification of cognitive impairment.
format Online
Article
Text
id pubmed-8570561
institution National Center for Biotechnology Information
language English
publishDate 2021
record_format MEDLINE/PubMed
spelling pubmed-85705612021-11-05 Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort Zhang, Larry Ngo, Anthony Thomas, Jason A. Burkhardt, Hannah A. Parsey, Carolyn M. Au, Rhoda Ghomi, Reza Hosseini Explor Med Article AIM: Although clinicians primarily diagnose dementia based on a combination of metrics such as medical history and formal neuropsychological tests, recent work using linguistic analysis of narrative speech to identify dementia has shown promising results. We aim to build upon research by Thomas JA & Burkardt HA et al. (J Alzheimers Dis. 2020;76:905-22) and Alhanai et al. (arXiv:1710.07551v1. 2020) on the Framingham Heart Study (FHS) Cognitive Aging Cohort by 1) demonstrating the predictive capability of linguistic analysis in differentiating cognitively normal from cognitively impaired participants and 2) comparing the performance of the original linguistic features with the performance of expanded features. METHODS: Data were derived from a subset of the FHS Cognitive Aging Cohort. We analyzed a sub-selection of 98 participants, which provided 127 unique audio files and clinical observations (n = 127, female = 47%, cognitively impaired = 43%). We built on previous work which extracted original linguistic features from transcribed audio files by extracting expanded features. We used both feature sets to train logistic regression classifiers to distinguish cognitively normal from cognitively impaired participants and compared the predictive power of the original and expanded linguistic feature sets, and participants’ Mini-Mental State Examination (MMSE) scores. RESULTS: Based on the area under the receiver-operator characteristic curve (AUC) of the models, both the original (AUC = 0.882) and expanded (AUC = 0.883) feature sets outperformed MMSE (AUC = 0.870) in classifying cognitively impaired and cognitively normal participants. Although the original and expanded feature sets had similar AUC, the expanded feature set showed better positive and negative predictive value [expanded: positive predictive value (PPV) = 0.738, negative predictive value (NPV) = 0.889; original: PPV = 0.701, NPV = 0.869]. CONCLUSIONS: Linguistic analysis has been shown to be a potentially powerful tool for clinical use in classifying cognitive impairment. This study expands the work of several others, but further studies into the plausibility of speech analysis in clinical use are vital to ensure the validity of speech analysis for clinical classification of cognitive impairment. 2021-06-30 2021 /pmc/articles/PMC8570561/ /pubmed/34746927 http://dx.doi.org/10.37349/emed.2021.00044 Text en https://creativecommons.org/licenses/by/4.0/This is an Open Access article licensed under a Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, sharing, adaptation, distribution and reproduction in any medium or format, for any purpose, even commercially, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Article
Zhang, Larry
Ngo, Anthony
Thomas, Jason A.
Burkhardt, Hannah A.
Parsey, Carolyn M.
Au, Rhoda
Ghomi, Reza Hosseini
Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort
title Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort
title_full Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort
title_fullStr Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort
title_full_unstemmed Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort
title_short Neuropsychological test validation of speech markers of cognitive impairment in the Framingham Cognitive Aging Cohort
title_sort neuropsychological test validation of speech markers of cognitive impairment in the framingham cognitive aging cohort
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570561/
https://www.ncbi.nlm.nih.gov/pubmed/34746927
http://dx.doi.org/10.37349/emed.2021.00044
work_keys_str_mv AT zhanglarry neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort
AT ngoanthony neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort
AT thomasjasona neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort
AT burkhardthannaha neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort
AT parseycarolynm neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort
AT aurhoda neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort
AT ghomirezahosseini neuropsychologicaltestvalidationofspeechmarkersofcognitiveimpairmentintheframinghamcognitiveagingcohort